Related Experiment Video
Updated: Apr 15, 2026

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
Signal transducer and activator of transcription 4 in liver diseases
Yan Wang1, Aijuan Qu2, Hua Wang3
11. Department of Infectious Diseases, Peking University First Hospital, Beijing 100034;
Abstract:
STAT4 is a member of the signal transducer and activator of transcription (STAT) family of molecules that localizes to the cytoplasm. STAT4 regulates various genes expression as a transcription factor after it is phosphorylated, dimerizes and translocates to the nucleus. STAT4 activation is detected virtually in the liver of several mouse models of liver injury, as well as the human liver of chronic liver diseases. STAT4 gene polymorphism has been shown to be associated with the antiviral response in chronic hepatitis C and drug-induced liver injury (DILI), primary biliary cirrhosis (PBC), HCV-associated liver fibrosis and in hepatocellular carcinoma (HCC). However, the roles of STAT4 in the pathogeneses of liver diseases are still not understood entirely. This review summarizes the recent advances on the functional roles of STAT4 and its related cytokines in liver diseases, especially in regulating hepatic anti-viral responses, inflammation, proliferation, apoptosis and tumorigenesis. Targeting STAT4 signaling pathway might be a promising strategy in developing therapeutic approaches for treating hepatitis in order to prevent further injury like cirrhosis and liver cancer.
Insights
Signal transducer and activator of transcription 4 (STAT4) plays a role in liver injury and disease. Targeting STAT4 may offer new therapies for liver conditions like hepatitis, cirrhosis, and liver cancer.
Area of Science:
- Molecular Biology
- Immunology
- Hepatology
Background:
- Signal transducer and activator of transcription 4 (STAT4) is a key signaling molecule.
- STAT4 activation is observed in various liver injury models and chronic liver diseases.
- STAT4 gene variations are linked to outcomes in hepatitis C, drug-induced liver injury, and liver cancer.
Purpose of the Study:
- To review the functional roles of STAT4 in liver disease pathogenesis.
- To highlight STAT4's involvement in hepatic anti-viral responses, inflammation, and cell fate.
- To explore STAT4 as a therapeutic target for liver diseases.
Main Methods:
- Literature review of STAT4's function in liver diseases.
- Analysis of STAT4's role in gene regulation, dimerization, and nuclear translocation.
- Examination of STAT4's association with cytokines and disease progression.
Main Results:
- STAT4 activation is prevalent in liver injury and chronic liver diseases.
- STAT4 influences hepatic anti-viral responses, inflammation, proliferation, apoptosis, and tumorigenesis.
- STAT4 gene polymorphisms correlate with disease outcomes and treatment responses.
Conclusions:
- STAT4 is implicated in the pathogenesis of diverse liver diseases.
- Understanding STAT4 signaling is crucial for comprehending liver disease progression.
- Targeting the STAT4 pathway presents a potential therapeutic strategy for liver diseases, including hepatitis, cirrhosis, and hepatocellular carcinoma.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Cell Specific Gene Expression
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Master Transcription Regulators
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

